Pages that link to "Q46536609"
Jump to navigation
Jump to search
The following pages link to Expression of MHC class II antigens in human lung cancer cells (Q46536609):
Displaying 14 items.
- Lymphocyte-activation gene-3, an important immune checkpoint in cancer (Q26746209) (← links)
- Evidence of recurrent atypical meningioma with rhabdoid transformation and expression of pyrogenic cytokines in a child presenting with a marked acute-phase response: case report and review of the literature (Q34428347) (← links)
- Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma (Q38287349) (← links)
- Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation. (Q38877252) (← links)
- Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA). (Q40589436) (← links)
- Proteomics analysis of human breast milk to assess breast cancer risk. (Q47343643) (← links)
- A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) production (Q57089649) (← links)
- Expression of ICAM‐1 in implanted primary and metastatic squamous cell carcinomas in rats (Q73901194) (← links)
- Prognostic significance of major histocompatibility complex class II antigens (HLA-DR) in normal colonic mucosa, tubulovillous adenoma, and invasive colonic carcinoma (Q83949705) (← links)
- Chemical and genetic control of IFNγ-induced MHCII expression (Q90320963) (← links)
- Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment (Q90353790) (← links)
- Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma (Q90370724) (← links)
- Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of FAM83A and FAM83B (Q93048863) (← links)
- Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers (Q99551841) (← links)